Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARTS-DN Japan: Finerenone Dose-Finding in Diabetic Nephropathy
NCT01968668Phase 2Completed
- Sponsor
- Bayer
- Start
- Oct 2013
- Primary completion
- Oct 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of finerenone in diabetic nephropathy (DN), sponsored by Bayer. Started Oct 2013; status: completed.
02
Drugs
finerenone
03
Conditions
diabetic nephropathy (DN)
Beyond the preview
Go deeper on NCT01968668.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01968668.